Drawing for EMRUSOLMIN

USPTO serial 97423939

EMRUSOLMIN

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
TMEG LAW OFFICE 101

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMRUSOLMIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy J. Maier

Timothy J. Maier MAIER & MAIER, PLLC345 SOUTH PATRICK ST.ALEXANDRIA, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes; Medicines for veterinary purposes; Pharmaceuticals and natural remedies; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemico-pharmaceutical preparations; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Dragees; Injectable pharmaceuticals; Medicinal preparations and substances; Antiparkinson agents; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzeimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of cerebral disease; Pharmaceutical preparations for the treatment of central nervous system diseasesACTIVE—
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research; Medical research laboratory services; Testing of pharmaceuticals; Analysis of human serum for medical research; Analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research services; Pharmaceutical research and development; Inspection of pharmaceuticals; Scientific research in the field of pharmacy; Scientific research and developmentACTIVE—
044Medication counseling; Providing information to patients in the field of administering medications; Provision of information relating to pharmaceutical products; Provision of information relating to the treatment of degenerative diseases; Provision of information relating to medical services; Provision of pharmaceutical information; Advisory services relating to the treatment of degenerative diseases; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Consultancy and information services relating to medical products; Advisory services relating to medicines; Medical services; Medical services for treating Alzheimer's disease; Pharmaceutical services; Preparation and dispensing of medicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2022MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jun 30, 2022ABN1ABANDONMENT - EXPRESS MAILED—
Jun 29, 2022EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 27, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 27, 2022ALIEASSIGNED TO LIE—
Jun 14, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 27, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance